» Articles » PMID: 34573900

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis

Overview
Specialty Radiology
Date 2021 Sep 28
PMID 34573900
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis is a multisystem disorder of unknown origin and poorly understood pathogenesis that predominantly affects lungs and intrathoracic lymph nodes and is characterized by the presence of noncaseating granulomatous inflammation in involved organs. The disease is highly heterogeneous and can mimic a plethora of other disorders, making diagnosis a challenge even for experienced physicians. The evolution and severity of sarcoidosis are highly variable: many patients are asymptomatic and their disease course is generally benign with spontaneous resolution. However, up to one-third of patients develop chronic or progressive disease mainly due to pulmonary or cardiovascular complications that require long-term therapy. The diagnosis of sarcoidosis requires histopathological evidence of noncaseating granulomatous inflammation in one or more organs coupled with compatible clinical and radiological features and the exclusion of other causes of granulomatous inflammation; however, in the presence of typical disease manifestations such as Löfgren's syndrome, Heerfordt's syndrome, lupus pernio and asymptomatic bilateral and symmetrical hilar lymphadenopathy, the diagnosis can be established with high level of certainty on clinical grounds alone. This review critically examines the diagnostic approach to sarcoidosis and emphasizes the importance of a careful exclusion of alternative diagnoses.

Citing Articles

A Case of Pulmonary Sarcoidosis With Multiple Endobronchial Polypoid Structures and Partial Airway Obstruction.

Orhun N, Ekin U, Rajab I, Sanchez J, Hazari A, Ismail M J Investig Med High Impact Case Rep. 2025; 13():23247096251313630.

PMID: 39849864 PMC: 11758509. DOI: 10.1177/23247096251313630.


Shifting temporal trends and disparities in sarcoidosis mortality in the United States: A retrospective analysis from 1999 to 2020.

Raza F, Kumar S, Mohammad A, Amin A, Ahmad F, Tousif S PLoS One. 2025; 20(1):e0317237.

PMID: 39792876 PMC: 11723600. DOI: 10.1371/journal.pone.0317237.


The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.

Puiu R, Motoc N, Lucaciu S, Ruta M, Rajnoveanu R, Todea D Biomolecules. 2024; 14(3).

PMID: 38540667 PMC: 10968628. DOI: 10.3390/biom14030247.


Noninfectious Granulomatous Lung Disease: Radiological Findings and Differential Diagnosis.

Lassandro G, Picchi S, Corvino A, Massimo C, Tamburrini S, Vanore L J Pers Med. 2024; 14(2).

PMID: 38392568 PMC: 10890318. DOI: 10.3390/jpm14020134.


Hepatic Sarcoidosis: Lesson Based on a Case Report.

Farina R, Clemenza M, Borzi S, Basile A J Med Ultrasound. 2024; 31(4):318-322.

PMID: 38264589 PMC: 10802865. DOI: 10.4103/jmu.jmu_62_22.


References
1.
Vihlborg P, Bryngelsson I, Andersson L, Graff P . Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study. BMJ Open. 2017; 7(7):e016839. PMC: 5642773. DOI: 10.1136/bmjopen-2017-016839. View

2.
ALLEN R . A review of angiotensin converting enzyme in health and disease. Sarcoidosis. 1991; 8(2):95-100. View

3.
Lacomis D . Neurosarcoidosis. Curr Neuropharmacol. 2012; 9(3):429-36. PMC: 3151597. DOI: 10.2174/157015911796557975. View

4.
Lynch 3rd J, Ma Y, Koss M, White E . Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007; 28(1):53-74. DOI: 10.1055/s-2007-970333. View

5.
Voortman M, Hendriks C, Elfferich M, Bonella F, Moller J, de Vries J . The Burden of Sarcoidosis Symptoms from a Patient Perspective. Lung. 2019; 197(2):155-161. PMC: 6486948. DOI: 10.1007/s00408-019-00206-7. View